Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001
-
Shares outstanding
-
303M
-
Number of holders
-
133
-
Total 13F shares, excl. options
-
115M
-
Shares change
-
-5.73M
-
Total reported value, excl. options
-
$592M
-
Value change
-
-$30M
-
Put/Call ratio
-
0.84
-
Number of buys
-
70
-
Number of sells
-
-69
-
Price
-
$5.14
Significant Holders of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) as of Q4 2019
169 filings reported holding PACB - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 as of Q4 2019.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) has 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 115M shares
of 303M outstanding shares and own 38.06% of the company stock.
Largest 10 shareholders include BlackRock Inc. (12M shares), VANGUARD GROUP INC (7.88M shares), CNH PARTNERS LLC (6.95M shares), Magnetar Financial LLC (6.92M shares), Bellevue Group AG (5.73M shares), Capital International Investors (5.28M shares), WATER ISLAND CAPITAL LLC (4.72M shares), GLENVIEW CAPITAL MANAGEMENT, LLC (3.81M shares), ArrowMark Colorado Holdings LLC (3.74M shares), and STATE STREET CORP (3.24M shares).
This table shows the top 133 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.